☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Solasia
Solasia Signs a License Agreement with Isofol to Develop and Commercialize Arfolitixorin for mCRC in Japan
August 14, 2020
PharmaShots Weekly Snapshots (August 10 - 14, 2020)
August 14, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
